Substance active
N/a,20mg **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Registres
Chaque registre avec son nombre de médicaments et quelques-uns d’entre eux.
États-Unis
FDA · 4 médicaments
- Halflytely5MG,N/A; 3350 N/A,210GM; 0.74GM; 2.86GM; 5.6GM, 5MG,N/A; 3350 N/A,210GM; 0.74GM; 2.86GM; 5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · for solution, tablet, delayed release · Braintree
- Helidac262.4MG,N/A,N/A; 250MG,N/A; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet, chewable, tablet, capsule · Casper Pharma LLC
- Omeclamox-Pak500MG,N/A,N/A; 500MG,N/A; 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · capsule, tablet, capsule, delayed release · Cumberland
- Suclear1.6GM/BOT,3.13GM/BOT,17.5GM/BOT,N/A,N/A,N/A,N/A; 3350 N/A,N/A,N/A,210GM,0.74GM,2.86GM,5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · solution · Braintree Labs
Tous les médicaments contenant N/a,20mg **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Tous les registres, page par page. Dosages et conditionnements figurent sur la page de chaque médicament.
4 résultats
| Médicament | Registre | Dosage | Forme | Statut | Titulaire |
|---|---|---|---|---|---|
| Omeclamox-PakAssociation | États-Unis | 500MG,N/A,N/A; 500MG,N/A; 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule, tablet, capsule, delayed release | Non commercialisé | Cumberland |
| SuclearAssociation | États-Unis | 1.6GM/BOT,3.13GM/BOT,17.5GM/BOT,N/A,N/A,N/A,N/A; 3350 N/A,N/A,N/A,210GM,0.74GM,2.86GM,5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution | Non commercialisé | Braintree Labs |
| HalflytelyAssociation | États-Unis | 5MG,N/A; 3350 N/A,210GM; 0.74GM; 2.86GM; 5.6GM, 5MG,N/A; 3350 N/A,210GM; 0.74GM; 2.86GM; 5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | for solution, tablet, delayed release | Non commercialisé | Braintree |
| HelidacAssociation | États-Unis | 262.4MG,N/A,N/A; 250MG,N/A; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, chewable, tablet, capsule | Non commercialisé | Casper Pharma LLC |